Related Experiment Video
Updated: Jul 9, 2026

Zika Virus Infectious Cell Culture System and the In Vitro Prophylactic Effect of Interferons
Published on: August 23, 2016
Predictive factors for interferon and ribavirin combination therapy in patients with chronic hepatitis C
Joonho Yoon1, Jong In Lee, Soon Koo Baik
1Department of Biochemistry and Institute of Basic Medical Sciences, Wonju College of Medicine, Yonsei University, 162 Ilsandong, Wonju, Gangwondo 220-701, Republic of Korea.
Aim:
To confirm the predictive factors for interferon (IFN)-alpha and ribavirin combination therapy for chronic hepatitis patients with hepatitis C virus (HCV) genotype 1b.
Methods:
HCV RNA from 50 patients infected with HCV genotype 1b was studied by cloning and sequencing of interferon sensitivity determining region (ISDR), PKR-eIF2alpha phosphorylation homology domain (PePHD). Patients were treated with IFN-alpha and ribavirin for 6 mo and grouped by effectiveness of the therapy. A variety of factors were analyzed.
Results:
Our data showed that age, HCV RNA titer, and ISDR type could be used as the predictive factors for combined IFN-alpha and ribavirin efficacy. Characteristically, mutations in PePHD appeared only when the combination therapy was effective. Other factors, such as sex and alanine aminotransferase (ALT) level, were not related to its efficacy. Adjusting for age and HCV RNA titer indicated that the ISDR type was the most potent predictive factor.
Conclusion:
HCV RNA ISDR type is an important factor for predicting efficacy of IFN-alpha and ribavirin combination therapy in Korean patients.
Related Concept Videos
Inhibitors of Viral Protein Synthesis
Hepatitis
Inhibitors Of Virion Release
Viral Hepatitis I: Introduction
Hepatic Drug Excretion: Influencing Factors
Antiviral Nucleoside Inhibitors
